abstract |
The present invention relates to a compound of general formula (I) wherein R is an amino or guanidino group; R 2 is acetyl or trifluoroacetyl; n and q may be the same or different; Selected from 0, 1 or 2; and X is optionally substituted phenyl, optionally substituted naphthyl, or optionally substituted phenyl-Y-optionally substituted phenyl (where , Y is a covalent bond, CH 2 , CH 2 CH 2 , O or SO 2 ), provided that when X is phenyl or naphthyl, n and q are both 2 and X is Phenyl and Y-phenyl (wherein Y is a covalent bond, n and q are not both 0}), or a pharmaceutically acceptable derivative thereof, a process for their preparation, Their use in the prevention or treatment of a pharmaceutical formulation or viral infection comprising. [Chemical 1] |